Hyperbaric oxygen therapy mitigates cochlear damage induced by a high-fructose diet: a histopathological study in rats

Abstract

Aims: Hearing loss, an increasing worldwide issue, has been associated with increased carbohydrate consumption. This study investigates the histopathological impact of a high-fructose diet (HFD) on cochlear structures and assesses whether hyperbaric oxygen therapy (HBOT) can mitigate those effects. Methods: Adult male Wistar rats were divided into four groups (n=8 each): control (standard diet, 10 weeks), HFD (60% fructose diet, 10 weeks), HBOT (standard diet+daily HBOT at 2.4 ATA for 1 h during weeks 9–10), and HFD+HBOT (60% fructose diet+HBOT in weeks 9–10). After 10 weeks, cochleae were took out and stria vascularis thickness, basilar membrane thickness, and inner/outer hair cell lengths were measured in basal, middle, and apical turns. Cochlear cross-sections stained with H&E and Masson’s trichrome, and evaluated histopathologically under light microscope. Results: Compared to controls, HFD-fed rats had thinner stria vascularis and basilar membranes in basal and intermediate turns and shorter hair cell lengths throughout all turns. The apical turn outer hair cell length and the middle and apical turns inner hair cell length increased statistically in HFD+HBOT rats compared to HFD alone. No significant changes were seen between HBOT-only and control groups. HFD induces considerable cochlear damage and cellular death in the organ of Corti in subjects. HBOT application somewhat mitigates these effects. Conclusion: A 10-week HFD induces region-specific cochlear structural degeneration in rats, and HBOT during the final two weeks partially reverses these changes. Future studies with larger sample sizes should include functional auditory assessments and explore underlying molecular mechanisms.

Keywords

• Hyperbaric oxygen therapy
• high-fructose diet
• inner hair cell
• organ of corti
• outer hair cell

Supporting Institution

None

Project Number

None

Ethical Statement

All procedures involving animals were approved by the Ethics Committee of Erciyes University (ERU HADYEK) (Date: 08.01.2025, Decision No: 25/025).

Hiperbarik oksijen tedavisi, yüksek fruktozlu diyetin neden olduğu koklear hasarı hafifletir: sıçanlarda histopatolojik bir çalışma

Abstract

Aims: Hearing loss, an increasing worldwide issue, has been associated with increased carbohydrate consumption. This study investigates the histopathological impact of a high-fructose diet (HFD) on cochlear structures and assesses whether hyperbaric oxygen therapy (HBOT) can mitigate those effects. Methods: Adult male Wistar rats were divided into four groups (n=8 each): control (standard diet, 10 weeks), HFD (60% fructose diet, 10 weeks), HBOT (standard diet+daily HBOT at 2.4 ATA for 1 h during weeks 9–10), and HFD+HBOT (60% fructose diet+HBOT in weeks 9–10). After 10 weeks, cochleae were took out and stria vascularis thickness, basilar membrane thickness, and inner/outer hair cell lengths were measured in basal, middle, and apical turns. Cochlear cross-sections stained with H&E and Masson’s trichrome, and evaluated histopathologically under light microscope. Results: Compared to controls, HFD-fed rats had thinner stria vascularis and basilar membranes in basal and intermediate turns and shorter hair cell lengths throughout all turns. The apical turn outer hair cell length and the middle and apical turns inner hair cell length increased statistically in HFD+HBOT rats compared to HFD alone. No significant changes were seen between HBOT-only and control groups. HFD induces considerable cochlear damage and cellular death in the organ of Corti in subjects. HBOT application somewhat mitigates these effects. Conclusion: A 10-week HFD induces region-specific cochlear structural degeneration in rats, and HBOT during the final two weeks partially reverses these changes. Future studies with larger sample sizes should include functional auditory assessments and explore underlying molecular mechanisms.

Keywords

• Hyperbaric oxygen therapy
• high-fructose diet
• inner hair cell
• organ of corti
• outer hair cel

Project Number

None

References

1. World Health Organization. Deafness and hearing loss. World Health Organization. Published 2025. Accessed June 1, 2025. https://www.who.int/news-room/fact-sheets/detail/deafness-and- hearing-loss
2. Puga AM, Pajares MA, Varela-Moreiras G, Partearroyo T. Interplay between nutrition and hearing loss: state of art. Nutrients. 2018;11(1):35. doi:10.3390/nu11010035
3. Gopinath B, Flood VM, McMahon CM, Burlutsky G, Brand-Miller J, Mitchell P. Dietary glycemic load is a predictor of age-related hearing loss in older adults. J Nutr. 2010;140(12):2207-2212. doi:10.3945/jn.110. 128462
4. Lee HJ, Yoo SG, Lee SJ, Han JS, Choi IY, Park KH. Association between HbA1c and hearing loss: a tertiary care center-based study. Sci Rep. 2023;13(1):18409. doi:10.1038/s41598-023- 44909-7
5. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537-543. doi:10.1093/ajcn/79.4.537
6. Rizkalla SW. Health implications of fructose consumption: a review of recent data. Nutr Metab (Lond). 2010;7:82. doi:10.1186/1743-7075-7-82
7. Bernardes N, Ayyappan P, De Angelis K, et al. Excessive consumption of fructose causes cardiometabolic dysfunctions through oxidative stress and inflammation. Can J Physiol Pharmacol. 2017;95(10):1078-1090. doi: 10.1139/cjpp-2016-0663
8. Cheng H, Zhou J, Sun Y, Zhan Q, Zhang D. High fructose diet: a risk factor for immune system dysregulation. Hum Immunol. 2022;83(6):538-546. doi:10.1016/j.humimm.2022.03.007

9. Mazzoli A, Spagnuolo MS, Nazzaro M, et al. Fructose removal from the diet reverses inflammation, mitochondrial dysfunction, and oxidative stress in hippocampus. Antioxidants (Basel). 2021;10(3):487. doi:10. 3390/antiox10030487
10. Baek JI, Kim YR, Lee KY, Kim UK. Mitochondrial redox system: a key target of antioxidant therapy to prevent acquired sensorineural hearing loss. Front Pharmacol. 2023;14:1176881. doi:10.3389/fphar.2023.1176881
11. Su Z, Chen Y, Liu Y, et al. Oxidative stress and inflammation combine to exacerbate cochlear damage and sensorineural hearing loss in C57BL/6 mice. Front Neurosci. 2025;19:1563428. doi:10.3389/fnins.2025.1563428
12. Baumann A, Brandt A, Bergheim I. Fructose, a trigger of metabolic diseases? A narrative review. Explor Dig Dis. 2022;1(1):51-71. doi:10.37349/edd.2022.00005
13. Jin J, Liu J, Luo Y, et al. High fructose induces dysfunctional vasodilatation via PP2A-mediated eNOS Ser1177 dephosphorylation. Nutr Metab (Lond). 2022;19(1):24. doi:10.1186/s12986- 022-00659-3
14. Brechtelsbauer PB, Nuttall AL, Miller JM. Basal nitric oxide production in regulation of cochlear blood flow. Hear Res. 1994;77(1-2):38-42. doi: 10.1016/0378-5955(94)90251-8
15. Choi Y, Han SJ, Kim SK, Hong SM. The therapeutic effect of hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss. Sci Rep. 2024;14(1):3321. doi:10.1038/s41598-024-53978-1
16. Cavaliere M, De Luca P, Scarpa A, et al. Combination of hyperbaric oxygen therapy and oral steroids for the treatment of sudden sensorineural hearing loss: early or late? Medicina (Kaunas). 2022;58(10): 1421. doi:10.3390/medicina58101421
17. Chen YC, Liu YH, Kang BH, et al. Hyperbaric oxygen therapy improves the effects of systemic steroid therapy for sudden sensorineural hearing loss. Heliyon. 2025;11:e42025. doi:10.1016/j.heliyon.2025.e42025
18. Joshua TG, Ayub A, Wijesinghe P, Nunez DA. Hyperbaric oxygen therapy for patients with sudden sensorineural hearing loss: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(1):5-11. doi:10.1001/jamaoto.2021.2685
19. Arslan HH, Satar B, Serdar MA, Ozler M, Yilmaz E. Effects of hyperbaric oxygen and dexamethasone on proinflammatory cytokines of rat cochlea in noise-induced hearing loss. Otol Neurotol. 2012;33(9):1672-1678. doi:10.1097/MAO.0b013e31826bf3f6
20. Lafère P, Vanhoutte D, Germonpré P. Hyperbaric oxygen therapy for acute noise-induced hearing loss: evaluation of different treatment regimens. Diving Hyperb Med. 2010;40(2):63- 67.
21. Su YT, Guo YB, Cheng YP, et al. Hyperbaric oxygen treatment ameliorates hearing loss and auditory cortex injury in noise exposed mice by repressing local ceramide accumulation. Int J Mol Sci. 2019; 20(19):4675. doi:10.3390/ijms20194675
22. Manji SS, Miller KA, Williams LH, Dahl HH. Identification of three novel hearing loss mouse strains with mutations in the Tmc1 gene. Am J Pathol. 2012;180(4):1560-1569. doi:10.1016/j.ajpath.2011.12.034
23. Shi TF, Zhou Z, Jiang WJ, et al. Hyperglycemia-induced oxidative stress exacerbates mitochondrial apoptosis damage to cochlear stria vascularis pericytes via the ROS-mediated Bcl-2/CytC/AIF pathway. Redox Rep. 2024;29(1):2382943. doi:10.1080/13510002.2024.2382943
24. Guo B, Guo Q, Wang Z, et al. D-Galactose-induced oxidative stress and mitochondrial dysfunction in the cochlear basilar membrane: an in vitro aging model. Biogerontology. 2020;21:311-323. doi:10.1007/s10522-020-09859-x
25. Kurata N, Schachern PA, Paparella MM, Cureoglu S. Histopathologic evaluation of vascular findings in the cochlea in patients with presbycusis. JAMA Otolaryngol Head Neck Surg. 2016;142(2):173-178. doi:10.1001/jamaoto.2015.3163
26. Psillas G. Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss. J Clin Med. 2023;12(4):1515. doi:10.3390/jcm 12041515
27. Lin CD, Wei IH, Lai CH, et al. Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase. BMC Neurosci. 2011;12:1-10. doi:10. 1186/1471-2202-12-21
28. Huo Z, Cheng X, Gu J, et al. Prognostic factors for hearing outcomes in patients that undergo adjuvant hyperbaric oxygen therapy for sudden sensorineural hearing loss. Laryngoscope Investig Otolaryngol. 2022; 7(2):592-598. doi:10.1002/lio2.768
29. Zhang Y, Jia X, Liu X, et al. Hyperbaric oxygen therapy promotes hearing gain with increases in serum IGF-1 and HSP70 in patients with idiopathic sudden sensorineural hearing loss. Evid Based Complement Alternat Med. 2022;2022:1368783. doi:10.1155/2022/1368783
30. Liu XH, Liang F, Jia XY, et al. Hyperbaric oxygen treatment improves hearing level via attenuating TLR4/NF-κB mediated inflammation in sudden sensorineural hearing loss patients. Biomed Environ Sci. 2020; 33(5):331-337. doi:10.3967/bes2020.045